Login to Your Account



Generic Pharma Pharmascience Buys Aegera, Oncology Programs

By Tom Wall


Tuesday, May 31, 2011
Aegera Therapeutics Inc. and its clinical-stage oncology programs were acquired by generic pharmaceutical company Pharmascience Inc., both based in Montreal.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription